Famciclovir
INDICATIONS
FDA
FDA
- Recurrent genital herpes (suppression and treatment) in immunocompetent and HIV+ pts.
- Treatment of herpes zoster.
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: January 6, 2020
Citation
Dzintars, Kathryn. "Famciclovir." Johns Hopkins ABX Guide, The Johns Hopkins University, 2020. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540219/all/Famciclovir.
Dzintars K. Famciclovir. Johns Hopkins ABX Guide. The Johns Hopkins University; 2020. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540219/all/Famciclovir. Accessed October 13, 2024.
Dzintars, K. (2020). Famciclovir. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540219/all/Famciclovir
Dzintars K. Famciclovir [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2020. [cited 2024 October 13]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540219/all/Famciclovir.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Famciclovir
ID - 540219
A1 - Dzintars,Kathryn,Pharm.D., BCPS
Y1 - 2020/01/06/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540219/all/Famciclovir
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -